These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35002736)

  • 1. What Is Valued Most by Patients With Type 2 Diabetes Mellitus When Selecting Second-Line Antihyperglycemic Medications in China.
    Liu S; Liu J; Yu Y; Si L; Tang C; Liu Z; Chen Y
    Front Pharmacol; 2021; 12():802897. PubMed ID: 35002736
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient preferences for anti-hyperglycaemic medication for type 2 diabetes mellitus in China: findings from a national survey.
    Liu S; Liu J; Si L; Ke X; Liu L; Ren Y; Bao S; Li F; Yu Y; Pan Q; Wei Y; Chen Y
    BMJ Glob Health; 2023 Apr; 8(4):. PubMed ID: 37041021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferences for medication attributes among patients with type 2 diabetes mellitus in the UK.
    Gelhorn HL; Stringer SM; Brooks A; Thompson C; Monz BU; Boye KS; Hach T; Lund SS; Palencia R
    Diabetes Obes Metab; 2013 Sep; 15(9):802-9. PubMed ID: 23464623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capturing Adult Patient Preferences Toward Benefits and Risks of Second-Line Antihyperglycemic Medications Used in Type 2 Diabetes: A Discrete Choice Experiment.
    Donnan JR; Johnston K; Chibrikov E; Marra CA; Aubrey-Bassler K; Najafzadeh M; Nguyen H; Gamble JM
    Can J Diabetes; 2020 Feb; 44(1):6-13. PubMed ID: 31311729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' Preferences for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.
    Banjara B; Poudel N; Garza KB; Westrick S; Whitley HP; Redden D; Ngorsuraches S
    Patient Prefer Adherence; 2022; 16():3415-3428. PubMed ID: 36597550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey.
    Mansfield C; Sikirica MV; Pugh A; Poulos CM; Unmuessig V; Morano R; Martin AA
    Diabetes Ther; 2017 Dec; 8(6):1365-1378. PubMed ID: 29101681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences for Patients with Type 2 Diabetes Mellitus for Medications in Shandong Province, China: A Discrete Choice Experiment.
    Lv Y; Ren R; Tang C; Song K; Li S; Wang H
    Patient Prefer Adherence; 2022; 16():2335-2344. PubMed ID: 36046499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of patients' preferences for osteoporosis medications and their attributes: the PREFER-International study.
    Duarte JW; Bolge SC; Sen SS
    Clin Ther; 2007 Mar; 29(3):488-503. PubMed ID: 17577470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes.
    Hauber AB; Han S; Yang JC; Gantz I; Tunceli K; Gonzalez JM; Brodovicz K; Alexander CM; Davies M; Iglay K; Zhang Q; Radican L
    Patient Prefer Adherence; 2013; 7():937-49. PubMed ID: 24086104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitus.
    Hauber AB; Tunceli K; Yang JC; Gantz I; Brodovicz KG; Alexander CM; Davies MJ; Radican L
    Diabetes Ther; 2015 Mar; 6(1):75-84. PubMed ID: 25586555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.
    Huang Y; Huang Q; Xu A; Lu M; Xi X
    Front Public Health; 2021; 9():782964. PubMed ID: 35178370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Preferences of Patients and the General Public for Treatment Outcomes in Type 2 Diabetes Mellitus.
    Crossnohere NL; Janse S; Janssen E; Bridges JFP
    Patient; 2021 Jan; 14(1):89-100. PubMed ID: 32885395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Preferences for Medications in Managing Type 2 Diabetes Mellitus: A Discrete Choice Experiment.
    Ozdemir S; Baid D; Verghese NR; Lam AY; Lee PC; Lim AY; Zhu L; Ganguly S; Finkelstein EA; Goh SY
    Value Health; 2020 Jul; 23(7):842-850. PubMed ID: 32762985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes.
    Hauber AB; Nguyen H; Posner J; Kalsekar I; Ruggles J
    Curr Med Res Opin; 2016; 32(2):251-62. PubMed ID: 26549576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences.
    Mühlbacher A; Bethge S
    Eur J Health Econ; 2016 Dec; 17(9):1125-1140. PubMed ID: 26682548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valuing injection frequency and other attributes of type 2 diabetes treatments in Australia: a discrete choice experiment.
    Fifer S; Rose J; Hamrosi KK; Swain D
    BMC Health Serv Res; 2018 Aug; 18(1):675. PubMed ID: 30165844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study.
    Qin L; Chen S; Flood E; Shaunik A; Romero B; de la Cruz M; Alvarez C; Grandy S
    Diabetes Ther; 2017 Apr; 8(2):321-334. PubMed ID: 28155131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods.
    Ratcliffe J; Couzner L; Flynn T; Sawyer M; Stevens K; Brazier J; Burgess L
    Appl Health Econ Health Policy; 2011; 9(1):15-27. PubMed ID: 21033766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient preferences for treatment in type 2 diabetes: the Italian discrete-choice experiment analysis.
    Marchesini G; Pasqualetti P; Anichini R; Caputo S; Memoli G; Ponzani P; Resi V; Rizzo M; Serviddio G; Zanette G
    Acta Diabetol; 2019 Mar; 56(3):289-299. PubMed ID: 30306406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specialty choice of medical students in China: a stated preference experiment.
    Liang D; Tang CX
    BMC Med Educ; 2016 Apr; 16():107. PubMed ID: 27068757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.